| Globalization of the Indian pharmaceutical industry: implications for innovation D Abrol, P Prajapati, N Singh Institutions and Economies, 327-365, 2011 | 57 | 2011 |
| In-vitro diagnostics (IVDs) innovations for resource-poor settings: The Indian experience N Singh, D Abrol Science, Technology and Innovation in BRICS Countries, 114-133, 2020 | 9 | 2020 |
| Pharmaceuticals, Product Patent and TRIPS Implementation D Abrol, S Dhulap, M Aisola, N Singh Institute for Studies in Industrial Development, Working Paper 191, 2016 | 5 | 2016 |
| Innovation patterns, limits to learning and the pathway of neoliberal globalisation: evidence from Indian pharmaceutical multinationals D Abrol, P Prajapati, N Singh International Journal of Technological Learning, Innovation and Development …, 2013 | 3 | 2013 |
| Statements on open science for sustainable development goals BH Chew, L Maxwell, FE Anyiam, A Menouni, TA Kurniawan, K Dimobe, ... Department of Family Medicine, Faculty of Medicine & Health Sciences …, 2024 | 2 | 2024 |
| Indian Pharmaceutical Industry Policy and Institutional Challenges of Moving from Manufacturing Generics to Drug Discovery DAN Singh Development with Global Value Chains: Upgrading and Innovation in Asia, 279-315, 2019 | 2 | 2019 |
| Esophageal Obstruction Associated with Enteral Feedings with Nepro®: an Unreported Event N Singh, SB Thapamagar, S Mukherjee J Gastroint Dig Syst S 1, 2, 2013 | 2 | 2013 |
| Building a Sustainable System for Emerging Healthcare Technologies: A Global South Perspective N Singh, R Kant, S Sinha, R John, F Khan India: T20 India. https://t20ind. org/wpcontent/uploads/2023/09 …, 2023 | 1 | 2023 |
| Molecular Diagnostics (MDs) Innovation Systems in India: Analysis of System Failures and Challenges N Singh Innovation Systems, Economic Development and Public Policy, 306-335, 2022 | 1 | 2022 |
| Development of Molecular Diagnostic Innovation System in India: Role of Scientific Institutions N Singh Asian Journal of Innovation and Policy 11 (1), 87-109, 2022 | 1 | 2022 |
| Economic liberalisation and the development of molecular diagnostics industry in India: An innovation system perspective N Singh The Routledge Handbook of Post-Reform Indian Economy, 361-390, 2021 | 1 | 2021 |
| Pharmaceutical Innovation and Contribution of In-house R&D of Domestic Firms after TRIPS in India D Abrol, N Singh ISID Working Paper, 2016 | 1* | 2016 |
| P99–2226: Acute cerebellitis and mutism associated with Rotavirus diarrhoeal illness M Joshi, P Harijan, N Singh, A Khan, N Hussain European Journal of Paediatric Neurology 19, S122, 2015 | 1 | 2015 |
| Genetic diversity in post-monsoon mungbean. RP Sinha, SK Sinha, NP Singh, AK Singh | 1 | 1999 |
| 2024 AAAS-TWAS Course on Science Diplomacy: Reflections & Insight SSN Singh Science Diplomacy Review 6 (4), 43-47, 2025 | | 2025 |
| National innovation system for CRISPR genome editing research in India: an empirical analysis. A Rajgharhia, N Nandana, P Parakh, S Sachdev, T Sravan, N Singh, ... Current Science (00113891) 127 (6), 2024 | | 2024 |
| 2024 AAAS-TWAS Course on Science Diplomacy: Reflections & Insights S Sinha, N Singh Science Diplomacy, 43, 2024 | | 2024 |
| Development of ‘TrueNat’Innovation System in India for Detection of Tuberculosis and COVID-19: A System Based Perspective N Singh, K Tyagi RIS, 2021 | | 2021 |
| India’s Domestic Pharmaceutical Firms and Their Contribution to National Innovation System-building NS Dinesh Abrol, Amitava Guha, Rollins John Economic & Political Weekly 115 (Special Issue), 35, 2019 | | 2019 |
| MALARIA INNOVATION SYSTEM IN INDIA: A SYSTEM BASED ANALYSIS PKPN Singh Journal of Applied and Universal Research 6, 2019 | | 2019 |